Razsejan, na kastracijo občutljiv rak prostate
, 2023 V zdravljenju razsejanega, na kastracijo občutljivega raka prostate (rKObRP) v zadnjem desetletju doživljamo pomembne spremembe. Prvim ugotovitvam, da imajo zlasti bolniki s primarno razsejanim rakom prostate z visokim bremenom bolezni korist od intenziviranja osnovnega odtegnitvenega hormonskega zdravljenja (ADT) z zgodnjo uvedbo citostatika ...
openaire +1 more source
Correction to Journal of Extracellular Biology Articles
Journal of Extracellular Biology, Volume 4, Issue 7, July 2025.
wiley +1 more source
Nemetastatski, na kastracijo odporen rak prostate
, 2023 Nemetastatski, na kastracijo odporen rak prostate (nKORP) je opredeljen kot porast vrednosti za prostato specifičnega antigena (PSA) po lokalnem zdravljenju ob kastracijski vrednosti testosterona, doseženi bodisi s kirurško ali medikamentozno odtegnitvijo androgenov ter brez dokazanih metastaz s konvencionalnimi radiološkimi metodami.
openaire +1 more source
Liječnički vjesnik, 2016 The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely
Gnjidić, Milena +8 more
openaire +1 more source
Tumor-stroma interactions influence the response to PI3K targeted agents in preclinical models of colorectal cancer (CRC) [PDF]
, 2019 Introduction: One of the main obstacle to the successful development of therapeutic strategies remains the identification of biomarker underlying drug resistance. Recently, investigators have become more aware the role of the tumor microenvironment (TME)
Bazzichetto, Chiara
core
, 2019 Oligometastatski rak prostate predstavlja prehodno stanje med omejeno in obsežno metastatsko boleznijo – gre za heterogeno skupino bolezni. Z izrazom večinoma opredeljujemo stanje z do največ petimi oddaljenimi zasevki. Standardno zdravljenje bolnikov z (oligo)metatstasko boleznijo je sistemsko zdravljenje.
openaire +2 more sources
Kliničke upute za dijagnostiku, liječenje i praćenje bolesnika oboljelih od raka mokraćnog mjehura Hrvatskoga onkološkog društva i Hrvatskoga urološkog društva Hrvatskoga liječničkog zbora [Clinical guidelines for diagnosing, treatment and monitoring patients with bladder cancer - Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association] [PDF]
, 2013 Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which ...
Fučkar, Željko +22 more
core
The role of polyphenols in the epigenetic regulation of tumor [PDF]
, 2018 Polifenoli su sekundarni biljni metaboliti koji u ljudskom tijelu pokazuju pozitivne učinke na različite bolesti, uključujući i tumore. Tumor nastaje kao posljedica genetskih i epigenetskih promjena, a polifenoli mogu utjecati na inhibiciju razvoja i ...
Mlinarić, Monika
core +2 more sources
Therapeutic and diagnostic applications of extracellular vesicles [PDF]
, 2016 De Smedt, Stefaan +2 more
core +1 more source
Down-regulation of Survivin enhances sensitivity to BPR0L075 in human cancer cells via caspase-independent mechanisms [PDF]
, 2008 Background: BPR0L075 [6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole] is a novel anti-cancer compound. It inhibits tubulin polymerization and induces mitochondrial-dependent apoptosis in various human cancer cells with different multi-
Chi-Yen Chang +5 more
core +1 more source